Background: Acinetobacter baumannii has emerged as an important pathogen causing a
variety of infections. Using data from the China Surveillance of Antimicrobial Resistance …

Because of its remarkable ability to acquire antibiotic resistance and to survive in
nosocomial environments, Acinetobacter baumannii has become a significant nosocomial …

Multidrug-resistant (MDR) Acinetobacter baumannii is one of the most important pathogens
in intensive care units related to morbidity and mortality, especially in ventilator-associated …

The potential of A. baumannii for acquired resistance to last resort antibiotics (colistin and
tigecycline) during treatment has important clinical implications, especially when dealing …

Background: Acinetobacter baumannii is a common cause of multi-drug (MDR)-resistant
infections worldwide. The epidemiological and molecular characteristics of MDR-A …

In vitro activity of tigecycline against 148 strains of Acinetobacter baumannii isolated from
different patients hospitalized at Siriraj Hospital, Bangkok, Thailand during 2002 to 2005 …

BACKGROUND: Multidrug-resistant Acinetobacter baumannii has presented a global
medical problem. Emergence of colistin resistance, including hetero-resistance, has been …

Abstract Background The Gastrointestinal Surgery Center (GISC)—Mansoura University,
faced a series of extensive drug resistant (XDR) A. baumannii cases, that were …

The in vitro susceptibility of clinical and environmental isolates of Acinetobacter baumannii
to tigecycline and other antibiotics was determined by disk diffusion method. The E-test was …

Acinetobacter baumannii is an opportunistic pathogen in healthcare facilities responsible for
nosocomial infections mostly in immunocompromised patients. Colistin resistance is …